Grass Is Always Greener? navigating SCPE Drug Policies & Cannabis

Wednesday, October 9, 2024

4:30 PM – 5:20 PM East Coast USA Time

Location: Chinatown (M3 Level)

CMEs: 0.75

Primary Speaker(s)

Jerry Weniger, PhD, ATC, PA-C

Program Director
James Madison University PA Program
Harrisonburg, Virginia

Slides Handouts

Co-Speaker(s)

Abby Massey, MD

Medical Director
James Madison University PA Program
Harrisonburg, Virginia
KL

Kristy Liskey, MPAS, PA-C

Director of Clinical Education
James Madison University PA Program
Harrisonburg, Virginia

Disclosure(s):

Jerry Weniger, PhD, ATC, PA-C: No financial relationships to disclose

Abby Massey, MD: No financial relationships to disclose

Kristy Liskey, MPAS, PA-C: No financial relationships to disclose

Description: We will discuss differences in cannabis derivatives (marijuana & CBD). Medicinal vs. recreational use, and the rapidly changing variation in state, federal, and local policies will also be discussed. There will be time for audience discussion about individual program’s drug testing policies and their impact on clinical rotation placement.

Learning Objectives:

Explain the various terminology associated with this topic including cannabis, THC, marijuana, hemp, CBD, and delta variants
Describe the differences between state, federal, and local (hospital) requirements, and how they may affect a PA program's drug testing policy
Discuss the changing landscape of cannabis in the United States from a federal and state perspective and how this affects PA programs and clinical site placements
Analyze and evaluate clinical site affiliation agreements for cannabis related language and adapt accordingly